Tag Archives: May 14

Obama trial, May 14, 2010, Dr. James David Manning, Columbia University Treason and Sedition Trial, Obama not natural born citizen, Obama did not attend Columbia University

Obama trial, May 145, 2010, Dr. James David Manning, Columbia University

In what could be a precursor to the indictment, impeachment and removal of Barack Obama from office, Dr. James David Manning is conducting a trial on May 14, 2010, empowered by the Tenth Amendment to the US Constitution.

From The Post & Email, April 27, 2010.

“We have proof of Obama’s ineligibility”

“Today The Post & Email welcomed back Dr. James David Manning, Ph.D., to speak about the upcoming Columbia University Treason and Sedition Trial which he is conducting in Harlem, NY, from May 14-19, 2010.  Dr. Manning reports that he has documented evidence that Barack Hussein Obama II is not a “natural born Citizen” as required by the U.S. Constitution to be President of the United States, and that Obama also did not attend Columbia University from 1981-83 as Obama has claimed.

MRS. RONDEAU: In your most recent video, you stated that a highly-placed government official will be testifying at the trial.  How did you get him to agree to testify, and will he be there in person or submitting something written?

DR. MANNING: Right now, we are anticipating at least two government officials will testify.  One will be through statements that will be uttered that will be documented, and the other will be a physical presentation where he will actually take the stand.

MRS. RONDEAU: And are they in government now or were they past employees of the federal government?

DR. MANNING: One is in government now, and one is a past employee.

MRS. RONDEAU: How did you reach out to them and when?

DR. MANNING: Actually, one reached out to me and the other became a matter of my investigation discovery.

MRS. RONDEAU: How long has the investigation lasted?

DR. MANNING: I have been following the Obama ineligibility issue from 2007, quite frankly, but more emphatically since the election on November 4, 2008.  That is when I began observing the issue of ineligibility more closely.  I have been on this matter for a couple of years now.

MRS. RONDEAU: How long have you had a formal investigation going on?

DR. MANNING: Six months or so.

MRS. RONDEAU: I know that the trial will take place May 14-19.  You’ve also mentioned a march around Columbia University.  Does that coincide with those dates, or will that be at a separate time?

DR. MANNING: The two are synonymous.

MRS. RONDEAU: Do you have any other key witnesses coming?

DR. MANNING: I have some very interesting witnesses that I have subpoenaed such that if they show up, it will be explosive.  If they don’t show up, we’re going to have them testify based on previous statements they have made, carefully observing the rules of evidence to enter those statements into evidence.  Having said that, I have subpoenaed George Stephanopoulos, Zbigniew Brzezinski, and Condolezza Rice; I have subpoenaed Michael Sovern, the President of Columbia University at the hour when the breach and the infractions took place; and I have subpoenaed Rod Blagojevich, whom I think is integral to a number of things that went on with the surrender of Barack Obama’s law license back in the spring of 2008 when Blagojevich was still governor; I want to talk to him about that.  I’ve subpoenaed all of the faculty that were a part of the Political Science program during the years that Obama would have been a student at Columbia University.

More recently, I have subpoenaed Louis Farrakhan and Jesse Jackson mainly because they were in Chicago in an eminent way during the years that Obama was an alleged community organizer.  Jesse Jackson was running PUSH and the Rainbow Coalition, and Louis Farrakhan was eminent in  forming the Million Man March, and Obama was allegedly a community organizer during a stretch of years.  I want to know what their relationship was and why they did not know him until he rolled into the Senate seat in Illinois some years later.  More specifically, the tenor of Chicago needs to be outlined by those two leaders.

I have also subpoenaed James Cone, who is a professor and the founder of the whole idea of Black Theology.  He wrote a very explosive book in the early ’80s outlining black theology.  He was the mentor of Jeremiah Wright, who was Obama’s pastor for 20 years.  Jeremiah Wright has developed his theology out of James Cone’s Black Theology; all the tenets which Wright preaches are based on Cone’s philosophical, religious and cultural outline.  I’ve subpoenaed him for two reasons.  One is that Dr. James Cone was an eminent professor at the Union Theological Seminary, which had a very close relationship with Columbia University.  During the years that Obama would have studied at Columbia, James Cone was right across the street as the most eminent black theologian in 1979-81.  Everyone on the planet was talking about James Cone then.  I want to ask James Cone this one question:  Why is it that he and Obama never knew each other with Obama being a black person searching for his roots, and James Cone right there  with everyone wanting an interview with him.  Why didn’t Obama take any classes with him?  The Union Theological Seminary and Columbia University were connected.”

“DR. MANNING: The  Tenth Amendment of the U.S. Constitution gives us the absolute, mandated right to call for a trial with a jury of we the people sanctioned by the Constitution if we discover that the courts or government officials are not executing their duties and allowing the people due process.  Thusly, the Constitution empowers our courts.  We, at times, will present evidence that crimes have taken place.  At that point, it becomes the responsibility of the officials to arrest those who have been charged with crimes in a public and duly-authorized hearing or court.  We will point out that crimes did take place.  If the court is duly authorized, then the contempt of that court is also an infraction, and you can be arrested for that as well.  So anyone who does not show up can be in contempt of a duly-authorized, Tenth Amendment, constitutionally-mandated court.  That’s the best way to answer that.”

“DR. MANNING: The trial, at present, is being structured by me, as a prosecutor, in three phases.   Phase One will demonstrate unequivocally with proof, with documentation, with statements, with a plethora of evidence that Obama is indeed not a natural born Citizen.  That would be the objective, and we will have evidence that will substantiate that at least 12 different acceptable ways.  From there, we will demonstrate that since he isn’t natural born, he violates the U.S. Constitution.  That’s No. 1.

The second stage of the trial will demonstrate that the alleged Columbia years were not spent at Columbia University and the issuance of the degree all over the place demonstrates that Obama did not attend Columbia in a traditional or non-traditional, satellite or correspondence course.  He was not enrolled in any of those courses.  We will demonstrate the type of program that Columbia had and the requirements for a political science major to complete and that Obama did not participate at that level, yet he was issued a degree.  We have the documentation at Stage 2 of the trial to demonstrate that both Columbia and Obama were in a criminal conspiracy to issue and to accept, respectively, knowing that he had not completed the required courses to have done so.”

 Read more:


NC Grand Jury Indictment of Obama, update, May 14, 2009, media attention, Observer News Enterprise in Newton, NC, Media and Congress will be accountable

I was born and raised in NC and though I have traveled over much of the US and some abroad, I have lived in NC all of my life. NC is a great state and I was always proud of it until this last election cycle. People known for having common sense and voting their conscience, regardless of political affiliation, lost their compass and like their counterparts in Nazi Germany, were mesmerized into voting for “change” and a candidate they knew little about.

The veil covering reality has been partially lifted and the real Barack Obama is beginning to appear. Citizen Grand Juries across the country are presenting indictments against the unqualified, usurper Obama. A strong case for treason is also being presented. Earlier today, the Citizen Wells blog brought news of a Grand Jury Indictment in NC. We have just been notified that a newspaper in Newton, NC has inquired about the indictment. It is hoped that the Observer News Enterprise will do their job and report on this important historic action. The Citizen Wells Blog will follow up on this and with your help we can “coax” other news media to actually do their jobs. Let your news outlets know that you want this covered.

Here is the update that we received:

“Believe it or not, I just received an e-mail from the editor of the Observer News Enterprise in Newton, NC, requesting that I answer a number of questions about my recent filing of the Obama indictment with Catawba County. (letter on request)  Here is my response in the form of a Letter To The Editor:”

“As many know, there is quite a controversy concerning Barack Obama’s eligibility to hold the office of President of the United States.  This controversy has spread to other nations and America’s credibility is now at stake among foreign governments.
On May 13, 2009, I filed, with the Catawba County Clerk of Court’s office, an indictment of Barack Hussein Obama for the commission of fraud and treason.  This indictment was handed down, on May 9, by a Citizen’s Grand Jury composed of jurors located in various states of the United States.  All laws governing Grand Juries were complied with.  The indictment was filed locally because it is the duty of any and all district attorneys to act on criminal charges… and I live here.  As I understand it, the indictment has been filed in other states in addition to North Carolina.
It is the hopes and expectations of the Grand Jury, and others, that District Attorney James C. Gaither will honor his Oath of Office and investigate these accusations.  If he will do so, it will require his bringing this case before a judge.  Once that is done, the judge will grant discovery.  “Discovery” is a term used to require that both sides put their cards on the table.  This is to avoid “trial by ambush”.  Once Mr. Obama is forced to submit his actual birth certificate, his school records, his college records and his immigration records, (which he has spent approximately one million dollars in concealing) the controversy will be settled.  He will either continue to be president or he will be removed from office.
This is not about Barack Obama. It is about our Constitution which states, “No person except a natural born Citizen, or a Citizen of the United States at the time of the Adoption of this Constitution, shall be eligible to the Office of President…” 
Mr. Obama has not satisfied this question.  It is now up to the courts to decide.”

“I also included the info below:”

On his first day in office, January 21, 2009, Obama signed Executive Order 13489.  This order was entered into the Federal Register on January 26, 2009.

What this executive order says, is that only the Attorney General (Eric Holder) and Council to the President, (Gregory Craig) are able to review presidential records requests and determine if they can be made public or not. (See Section 3)

In other words, you aren’t going to see any records or documents that Obama doesn’t want you to see.

It shouldn’t surprise anyone that Obama’s first official act was to deny access to his records.  Obama has lived for 48 years without leaving any footprints — none!  There is no Obama documentation — no bona fides — no paper trail — nothing.

Original, vault copy birth certificate — Not released
Certificate of Live Birth — Released — Counterfeit
Obama/Dunham marriage license — Not released
Obama/Dunham divorce — Released (by independent investigators)
Soetoro/Dunham marriage license — Not released
Soetoro adoption records — Not released
Soetoro/Dunham divorce — Released (by independent investigators)
Fransiskus Assisi School  School application — Released (by independent investigators)
Punahou School records — Not released
Selective Service Registration — Released — Counterfeit
Occidental College records — Not released
Passport — Not released and records scrubbed clean by Obama’s terrorism and intelligence adviser.
Columbia College records — Not released
Columbia thesis — Not released
Harvard College records — Not released
Harvard Law Review articles — None
Baptism certificate — None
Medical records — Not released
Illinois State Senate records — None
Illinois State Senate schedule — Lost
Law practice client list — Not released
University of Chicago scholarly articles — None”

If anyone from the Observer News Enterprise in Newton, NC, or any other media outlet has any questions, I will answer them.

Citizen Wells

H1N1 flu update, May 14, 2009, CDC, Pregnant women risks, population has little to no immunity, Mutations, risk that the viruses will exchange genetic material and get worse

Here is the latest report from the CDC. Three aspects of the H1N1 flu strike me as significant.

  • “The population has little to no immunity against it.”
  • “Pregnant women are at higher risk of complications of influenza.” “We are also seeing some severe complications among pregnant women in this year’s novel H1N1 virus problem” “I think that the H1N1 virus that we’re dealing with is novel, and so, we don’t think pregnant women have ever seen this before or would be protected from it from years past.”
  • “Unfortunately, reassortment happens. And this means that the viruses that we’re seeing can exchange genetic material with other viruses that are circulating. This can happen in humans, in pigs, in birds. And so, we do always have a risk that the viruses will exchange genetic material and get worse, or hopefully, get better, if they do that. So, we do think that the simultaneous occurrence in the world right now of this novel H1N1 strain that appears to be very transmissible, and very virulent H5N1 (Editor′s note – this is a correction) strains that are endemic in animals in certain countries of the world in the avian population, and the seasonal H1N1 strain that is oseltamivir resistant is an unusual circumstance.”

Do not panic. Stay informed.

If you are pregnant, take extra precautions and if possible limit your exposure.

A decision to take a vaccine must be carefully weighed.

U.S. Human Cases of H1N1 Flu Infection
(As of May 13, 2009, 11:00 AM ET)  States* Laboratory
cases Deaths
Alabama 9  
Arizona 187  
California 221  
Colorado 44  
Connecticut 33  
Delaware 54  
Florida 58  
Georgia 8  
Hawaii 6  
Idaho 3  
Illinois 592  
Indiana 70  
Iowa 55  
Kansas 23  
Kentucky** 10  
Louisiana 33  
Maine 6  
Maryland 23  
Massachusetts 107  
Michigan 134  
Minnesota 31  
Missouri 18  
Montana 1  
Nebraska 21  
Nevada 21  
New Hampshire 17  
New Jersey 8  
New Mexico 44  
New York 211  
North Carolina 12  
Ohio 11  
Oklahoma 22  
Oregon 74  
Pennsylvania 22  
Rhode Island 7  
South Carolina 32  
South Dakota 3  
Tennessee 57  
Texas 293 2
Utah 72  
Vermont 1  
Virginia 17  
Washington 176 1
Washington, D.C. 9  
Wisconsin 496  
TOTAL*(45) 3352 cases 3 deaths
*includes the District of Columbia

**one case is resident of KY but currently hospitalized in GA.

Press Briefing Transcripts

CDC Telebriefing on Investigation of Human Cases of H1N1 Flu

May 12, 2009, 12:30 p.m. ET

Operator: Welcome, and thank you all for standing by.  At this time, I would like to remind parties in your lines are in a listen-only mode until the question-and-answer session, at which time, press star one to ask a question.  Today’s call is being recorded.  If you have any objections, you may disconnect at this time.  I’ll now turn the meeting over to Tom Skinner, you may begin.

Tom Skinner: Thank you for joining us for the update of an investigation into a novel strain of H1N1.  With us today is Dr. Anne Schuchat.  That is spelled A-N-N-E.  Last name is S-C-H-U-C-H-A-T.  She is the Interim Deputy Director for Science and Public Health program here at CDC.  She’s going to be providing some opening comments and then we’ll turn it over to reporters for Q&A.  So, Dr. Schuchat? 

Anne Schuchat: Great.  Good afternoon, everyone.  What I want to do is give you a quick situation update; talk little bit in more detail about a clinical group of patients, and then make some closing comments about where I think we are in this investigation. 

So, as of today, there are about 3,600 probable and confirmed cases in 46 states and the District of Columbia.  We have 3,002 confirmed cases in 44 states and D.C., with the most recent onset May 5th.  As you know, there have been three reported fatalities confirmed to be due to the H1N1 virus.  We have 116 hospitalizations that are being investigated at this point.  Most of those have been confirmed to be due to the H1N1 virus.  Our median age remains low at 15 years with a range, though, of 1 month of age up to 86 years.  Almost two-thirds of our confirmed cases are under 18.  Around the world, the case counts are continuing to increase.  There’s a total of 5,251 confirmed cases according to the World Health Organization, and those are occurring in 30 countries with Canada being and the United Kingdom having the largest number of confirmed cases after the U.S. and Mexico. 

In terms of our U.S. situation, you know we’ve had a active response with more than 100 field staff deployed to help with investigations in this country and Mexico.  We’ve deployed the test kits to the states, and I’m happy to report that as of today, 29 of the states are now doing their own confirmatory testing for the novel H1N1 strain.  We’ve sent the lab kits to a number of countries around the world, and testing is a critical part of understanding the situation around the world.  As we continue to investigate, we learn more and we want to share information as we get it. 

I wanted to say a few words today about this novel H1N1 influenza virus and pregnancy.  As many of you know, pregnant women are at higher risk of complications of influenza, whether it’s the seasonal influenza or pandemics of the past.  We are also seeing some severe complications among pregnant women in this year’s novel H1N1 virus problem, and I really want to make you aware of that, because I think it’s something that can have important clinical benefit.  We have about 20 cases under investigation right now where the H1N1 virus has been found in association with pregnancy.  We’re continuing to understand the illness in these patients, and a few of the patients have had severe complications.  As I think many of you know there was one fatality in a pregnant woman.  Influenza can cause worse complications in pregnancy than in people who are not pregnant.  Important complications include pneumonia and dehydration as well as complications for the newborn, like premature labor.  We think it’s very important when doctors are caring for pregnant women who they suspect may have influenza, that they issue prompt treatment with antiviral medicines.  Sometimes, physicians are reluctant to treat pregnant women with medicines, and sometimes pregnant women are reluctant to take medicines because, of course, they are sometimes risky during pregnancy.  The experts who have looked into this situation really strongly say that the benefits of using antiviral drugs to treat influenza in a pregnant woman outweigh the theoretical concerns about the drugs.  We think that either of the two medicines that this virus is susceptible to it be used for this condition.  So, while we don’t have lots and lots of experience yet with this H1N1 virus in pregnancy, it’s important to know, to look back on what we do know about seasonal influenza and pregnancy.  We strongly recommend pregnant women receive the seasonal flu vaccine to protect them from complications of influenza during pregnancy.  And for this novel H1N1 virus, we really want to get the word out about the likely benefits of prompt antiviral treatment in pregnancy when you’re suspecting influenza.  We are going to be issuing an MMWR report with some clinical and some data about the pregnancy cases that we’ve been investigating, and I think I would look for that to come out fairly soon with a little bit more detail than what I’ve shared. 

Yesterday at the media briefing, a few of you had questions about a recent article that came out in “Science Express.”  I think it came out two minutes before the press conference yesterday, so I wasn’t fully prepared, but I wanted to make a couple comments about this.  It’s an article by Christoph Frasier and colleagues called “Pandemic Potential of a Strain of Influenza: H1N1 Early Findings.”  This was a modeling analysis looking at data from Mexico in collaboration with investigators there.  And I think it’s very important that the infectious disease modeling community is aggressively responding to this novel virus and trying to share lessons learned in real time.  It’s important to say that uncertainty remains, that we’re learning more about transmissibility and attack rates.  In the article, the authors concluded that the virus characteristics in Mexico were not of the severity or transmissibility that we had seen in the 1918 pandemic, but they compared it with something of a magnitude of the 1957 pandemic.  It’s important to say that we may see changes as this virus is present in different countries, depending on the health care resources of the countries and the types of interventions that are carried out as well as potential changes that the virus goes through, as influenza viruses can mutate and evolve in the course of their spread.  So, I think this was an important report, and I applaud the authors for taking on this topic, and we hope that the international community will continue to collaborate to learn as much as we can about this new virus and how it behaves in large populations. 

I also want to comment about seasonal influenza.  We have been mentioning, and on our website, you see that we have cases of the regular seasonal flu strains, the seasonal A-H1N1, the seasonal A-H3N2 (Editor′s note – this is a correction), and the seasonal B viruses.  They are continuing to circulate now at a time when this novel H1N1 virus is also circulating.  One thing you can see from our flu view on the website is that there is an uptick of these other viruses in addition to the H1N1 virus.  We don’t think that there was a decrease in seasonal flu and then an increase in seasonal flu.  We think that pattern suggests that more people with influenza-like symptoms are being tested and more of those viruses are being studied so that our efforts to respond to this outbreak have led to recognition of more seasonal influenza.  It’s important to say that a large proportion of the strains currently being tested are due to this novel H1N1 virus, but there are other strains circulating.  So, that’s an important occurrence.  It maybe foreshadows what we have to face next fall, when seasonal strains of influenza are likely to circulate, and we may see this H1N1 strain come back, perhaps, in worse or milder form. 

The last comment is just to continue to say that vaccine development efforts have been of interest.  This is the time when we are growing up isolates to potentially identify a candidate virus that would be handed off to manufacturers to work on manufacturing or development stages.  CDC has sent five isolates to several different institutions around the world where candidate vaccines, viruses could be developed.  And there are active discussions being carried out across the U.S. government, including with manufacturers, to understand next steps and potential vaccine development and manufacturing.  So, in closing my prepared remarks, I just want to say that I think we are transitioning to the long view now.  We have a focus on the southern hemisphere, where illness may be on the upswing soon, and where we hope to learn as much as possible to help them respond and also to learn for what might be the case here in the northern hemisphere next year.  We’re also preparing for the fall, including exploration of vaccine development and manufacturing discussions.  We’re also trying to learn as much as we can from the experience of the past few weeks so that we can be better prepared going forward.  So, with that, I’d like to answer questions that you might have. 

Tom Skinner: First question, Rose? 

Operator: Our first question is from Elizabeth Weise, USA Today.  Your line is open.

Elizabeth Weise: Hi, thank you for taking my question.  I wanted to go back to your focus on pregnant women and the specific problems they face.  You said you have about 20.  Do you have any sense of percentages, about what percentage of pregnant women might be at risk for this?  Is pregnancy in and of itself the main, underlying condition, or is it pregnant women who also have other underlying conditions as well? 

Anne Schuchat: Pregnancy is a well-documented risk factor for complications of influenza.  It’s not that we think pregnant women get influenza, seasonal flu, for instance, more than other people, but we think when they suffer an infection with influenza, they can have a worse time.  For instance, they may develop pneumonia, they may develop dehydration, and their metabolic system may not be able to handle the infection as well.  So, there are a number of reasons that pregnant women can have a worse time, including some complications, such as preterm labor and complications for the newborn.  So, this is a group that we include among our populations at higher risk for influenza complications, and that’s why for the past several years we’ve been strongly recommending women who are pregnant receive the influenza vaccine, to protect them and to have a better outcome of their pregnancy. 

Elizabeth Weise: Follow-up question.  Is there then the sense that this H1N1 novel influenza is any worse or better than seasonal flu when it comes to pregnant women, or is it just you’re trying to reiterate to women that they shouldn’t be afraid to take antivirals and to see a doctor if they get it? 

Anne Schuchat: You know, I think that the H1N1 virus that we’re dealing with is novel, and so, we don’t think pregnant women have ever seen this before or would be protected from it from years past.  Many years with seasonal flu strains circulating, a lot of pregnant women may have some immunity to the strands that are circulating.  We still think vaccination’s a good idea for pregnant women, but I think because of this — because this H1N1 virus is targeting younger people and because it’s totally new and because we know that pregnancy is a risk factor for worse complications, we really want to focus our attention on it and make sure that pregnant women and their health care providers have this concern in mind.  Next question? 

Operator: The next is from Jennifer Corbett, Dow Jones.  Your lone is open.

Jennifer Corbett: Yeah, hi.  I have two questions.  The one — do you recommend for seasonal flu that women, pregnant women, take antivirals or is this specific to the H1N1?  And then the other question I had is at the top you mentioned that there’s been a death of a pregnant woman.  Was that one of the women in Texas?  Was she the one in Texas? 

Anne Schuchat: That’s right about the fatality we do think that when influenza occurs in pregnancy, it should be treated with antivirals.  The message today, the time of year we’re at right now, the majority of what we’re seeing that is influenza-like illness, or half of what we’re seeing is this H1N1 strain, so it’s in this circumstance that we’re really trying to remind people that treatment of influenza-like illness in pregnancy is appropriate.  We don’t know as much as we would like to know about the H1N1 virus that we’re seeing.  And certainly, every day we’re learning little bit more.  As we’ve accumulated some experience with this illness, we are trying to share clinical, interim clinical recommendations.  So, I think that things could change as we get further along in the investigation, but so far, of course, one of our three fatalities was a very sad story in a woman who was pregnant.  Next question, please? 

Operator: The next is from Mike Stobbe, Associated Press. Your line is open.

Mike Stobbe: Hi, thanks for taking the call.  Doctor, that “Science” article had an estimate about when the virus might have first appeared.  Can you tell us, you know, as this has been going on, what’s science telling you at this point about when it first appeared?  Did it first appear in a pig?  Who infected who?  Do you have any update on that?  And I have a second question. 

Anne Schuchat: Yeah, the paper in “Science” talked about beginning — there’s a virus emerging in the middle of February, and I think the working hypotheses for much of the influenza community right now is that this strain was circulating in pigs somewhere, and eventually, you know, reassorted and was able to infect humans easier, the people got it and then it became easily transmitted between people.  That’s a working hypothesis, but of course, the scientific community and CDC included is very open to other hypotheses.  We don’t have new information about the specific origins.  We think that’s an important investigation that the scientific and public health community is taking on, but so, the clinical illness — that paper suggested mid-February, and we don’t have reason to believe that humans were having a large problem with this before that.  But of course, you know, investigations are active in a number of places. 

Mike Stobbe: Okay.  My second question — we’ve begun to see announcements from companies about the availability of commercial tests for this novel virus coming online.  Can you assess those for me?  Are those good tests?  Are they solid?  Are they starting to contribute to the case counts? 

Anne Schuchat: I won’t — I don’t have the information to be able to answer the question.  I’m sorry.  I think that it’s — you know, we have disseminated information on sequence and the primers and probes that can be used to identify this virus.  We’ve also distributed agents and test kits for the public health laboratory network to be able to recognize this.  It’s very possible for manufacturers, biotech companies, to make kits that would work similarly to the ones the CDC has distributed.  There’s usually a validation process that goes forward, and I’m not — I don’t know whether there’s any systemic evaluation of the commercially produced kits that — I don’t know if CDC’s involved in any of that.  So, sorry about that.

Tom Skinner: Next question, Rose.

Operator: The next is from Michael Smith, Med Page Today.  Your line is open.

Michael Smith: Dr. Schuchat, you talked about antivirals in connection with pregnant women.  On the Hubra press conference earlier today, they said that antivirals are being aggressively used in Europe, where they’re mainly employee cases, and were being reserved really largely for serious cases in the U.S. and Mexico.  Can you comment on how antivirals are being used in the U.S.? 

Anne Schuchat: Yes, that’s right.  The circumstances in the U.S. are very different from the circumstances in a number of European countries.  We have this virus in every — pretty much, almost every state in the country, and suspected it’s likely already to the states that haven’t confirmed it yet.  We don’t have a situation where we can contain the virus’s geographic distribution, and our focus is on reducing illness and death and mitigating the impact that this virus has as well as focusing our efforts on areas where they can have the most impact.  So, the priority here is for antiviral drugs for treatment of influenza, where we think the treatment will make a difference, and that’s for people with severe illness presentation or for people who have underlying medical conditions or pregnancy, where the complications of an influenza infection might be worse than in other people.  So, our focus for antiviral drugs is primarily on treatment.  And we are aware that there are some other countries where there’s a lot of preventive use of antiviral drugs around the traveler, around the first case that they’ve seen.  That circumstance is not likely to have a benefit here in the United States based on the transmission patterns we’re seeing and the stage of the outbreak that was present by the time we recognized this virus.  Did you have a follow-up question, or —

Michael Smith: No, that’s good.  Thank you. 

Anne Schuchat: Okay.  Is there another question? 

Operator: The next is from Emma Hitt, Medscape, your line is open.

Emma Hitt: Yes, hi, thank you for taking my question.  You talk about the novel H1N1 virus coming back during the fall.  Is that a certainty?  And will it definitely pick up back in the fall?  And also, do you expect the H1N1 virus to be more robust during the summer months than the seasonal flu strain? 

Anne Schuchat: We wish that we knew what was going to happen in the fall.  Influenza is usually seasonal, and usually, there is very limited circulation in the northern hemisphere during our summer months.  But there is increased circulation in the southern hemisphere during that same time period.  We don’t know whether the novel H1N1 virus will circulate in the U.S. next fall, and if it circulates, whether it will be more severe, of similar severity or less severe than now.  We think that if we have good information coming from the southern hemisphere and we see a lot of disease or severe disease associated with this virus, that that would increase the likelihood that we would continue to see problems in the fall.  But we, unfortunately, cannot predict.  The other thing is that these viruses continue to change.  Because we have seasonal influenza strains, including an H1N1 strain that is resistant to oseltamivir and zinamivir.  But because we have an H1N1 strain that’s circulating that’s resistant and we have this novel H1N1 strain, we also don’t know whether there might be a reassortment between the human seasonal flu strain and the novel strain.  So, there’s a lot of unknowns, a lot of uncertainties and a real priority to have good laboratory surveillance and monitoring of the circumstances in the southern hemisphere and the ongoing occurrence here in the U.S.  Next question? 
Operator: The next is from Allen Miranda.  Your line is open. 

Alan Miranda: Hi.  Well, I would like to follow up on what you just said.  You said also at the beginning that there are also other kinds of viruses circulating.  And I was about to ask you, if this virus could reassort with any other kind, any other strain, Avian flu, for instance. 

Anne Schuchat: Unfortunately, reassortment happens. And this means that the viruses that we’re seeing can exchange genetic material with other viruses that are circulating.  This can happen in humans, in pigs, in birds.  And so, we do always have a risk that the viruses will exchange genetic material and get worse, or hopefully, get better, if they do that.  So, we do think that the simultaneous occurrence in the world right now of this novel H1N1 strain that appears to be very transmissible, and very virulent H5N1 (Editor′s note – this is a correction) strains that are endemic in animals in certain countries of the world in the avian population, and the seasonal H1N1 strain that is oseltamivir resistant is an unusual circumstance.  Certainly, our efforts to control seasonal influenza with our annual immunization campaign will be important, and of course, there are discussions going on about vaccine development and potentially manufacturing and even use, eventually, of an H1N1 virus vaccine.  Those are important discussions, as well as the ongoing efforts to try to control the Avian H5N1 problem in birds in some of the world.  Next question? 

Operator: I’m showing no questions at this time. 

Tom Skinner: Okay.  Rose, thank you, and thank you all for joining us for this update.  Please stay tuned and continue to go to http://www.cdc.gov for updated information, and we’ll keep you apprised as developments warrant.  Thank you. 




Sean Hannity, Reverend Manning interview, Wednesday, May 14, 2008, Obama homosexual, Obama and Wright homosexuals, Manning has proof

Sean Hannity interviewed the Reverend James Manning on his radio show on Wednesday, May 14, 2008. Reverend Manning accused Obama and Wright of being closet homosexuals on a YouTube video last weekend. I am not sure what Hannity’s strategy is. He may fear racist comments. I do applaud Hannity for interviewing Reverend Manning even though Hannity barely stopped talking the entire time.

If you would like to hear a real interview of reverend Manning, listen to the Jeff Rense interview here: